Comparison Overview
ConnectMed360

ConnectMed360
13410 Eastpoint Centre Drive, Suite 150, Louisville, 40223, US
Last Update: 27/03/2026
WHO WE ARE ConnectMed360 is a leader in commercialization services for the healthcare industry connecting pharmaceutical manufacturers with providers and patients to deliver value and efficiency across all channels. OUR MISSION + VISION As a healthcare company dedicate...

Teva Pharmaceuticals
124 Dvora hanevi'a, Tel-Aviv, IL, 6944020
Last Update: 28/03/2026
Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicin...
Compliance Ranges Comparison

ConnectMed360







Teva Pharmaceuticals






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for ConnectMed360 in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Teva Pharmaceuticals in 2026.
Incident History - ConnectMed360 (X = Date, Y = Severity)
ConnectMed360 cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Teva Pharmaceuticals (X = Date, Y = Severity)
Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

ConnectMed360

Teva Pharmaceuticals
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.